Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Disaster mitigation: initial response.

Kennedy G, Richards M, Chicarelli M, Ernst A, Harrell A, Stites D.

South Med J. 2013 Jan;106(1):13-6. doi: 10.1097/SMJ.0b013e31827cb037.

PMID:
23263307
2.

Immune function declines with unemployment and recovers after stressor termination.

Cohen F, Kemeny ME, Zegans LS, Johnson P, Kearney KA, Stites DP.

Psychosom Med. 2007 Apr;69(3):225-34. Epub 2007 Mar 30.

PMID:
17401058
3.

Improving methods of assessing natural killer cell cytotoxicity.

Sephton SE, Kraemer HC, Neri E, Stites DP, Weissbecker I, Spiegel D.

Int J Methods Psychiatr Res. 2006;15(1):12-21.

PMID:
16676682
4.

Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer.

Blake-Mortimer JS, Sephton SE, Carlson RW, Stites D, Spiegel D.

Breast J. 2004 May-Jun;10(3):195-9.

PMID:
15125744
5.

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens.

Nakagawa M, Stites DP, Patel S, Farhat S, Scott M, Hills NK, Palefsky JM, Moscicki AB.

J Infect Dis. 2000 Aug;182(2):595-8. Epub 2000 Jul 28.

PMID:
10915094
6.
7.

Semi-automated entry of clinical temporal-abstraction knowledge.

Shahar Y, Chen H, Stites DP, Basso LV, Kaizer H, Wilson DM, Musen MA.

J Am Med Inform Assoc. 1999 Nov-Dec;6(6):494-511.

8.

Th1 cytokine patterns in cervical human papillomavirus infection.

Scott M, Stites DP, Moscicki AB.

Clin Diagn Lab Immunol. 1999 Sep;6(5):751-5.

9.

CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses.

Nakagawa M, Stites DP, Palefsky JM, Kneass Z, Moscicki AB.

Clin Diagn Lab Immunol. 1999 Jul;6(4):494-8.

10.

Differential immune system changes with acute and persistent stress for optimists vs pessimists.

Cohen F, Kearney KA, Zegans LS, Kemeny ME, Neuhaus JM, Stites DP.

Brain Behav Immun. 1999 Jun;13(2):155-74.

PMID:
10373279
11.

Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways.

Spiegel D, Sephton SE, Terr AI, Stites DP.

Ann N Y Acad Sci. 1998 May 1;840:674-83. Review.

PMID:
9629294
12.

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia.

Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM.

J Infect Dis. 1997 Apr;175(4):927-31.

PMID:
9086151
13.

Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay.

Gniewek RA, Stites DP, McHugh TM, Hilton JF, Nakagawa M.

Clin Diagn Lab Immunol. 1997 Mar;4(2):185-8.

14.

T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.

Nakagawa M, Stites DP, Farhat S, Judd A, Moscicki AB, Canchola AJ, Hilton JF, Palefsky JM.

Clin Diagn Lab Immunol. 1996 Mar;3(2):205-10.

15.

Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis.

Kirn DH, Fredericks D, McCutchan JA, Stites D, Shuman M.

Clin Infect Dis. 1995 Oct;21(4):1048-9. No abstract available.

PMID:
8645808
16.

Marked elevation of the serum ferritin is highly specific for disseminated histoplasmosis in AIDS.

Kirn DH, Fredericks D, McCutchan JA, Stites D, Shuman M.

AIDS. 1995 Oct;9(10):1204-5. No abstract available.

PMID:
8519465
17.
18.

A simple method for the propagation of cervical lymphocytes.

Moscicki AB, Hunter SD, Garland S, Quinn M, Crowe SM, Shortman K, Stites D.

Clin Diagn Lab Immunol. 1995 Jan;2(1):40-3.

19.

Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis.

Silverman S Jr, Kaugars GE, Gallo J, Thompson JS, Stites DP, Riley WT, Brandt RB.

Oral Surg Oral Med Oral Pathol. 1994 Oct;78(4):442-7.

PMID:
7800374
20.

HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.

Liegler TJ, Stites DP.

J Acquir Immune Defic Syndr. 1994 Apr;7(4):340-8.

PMID:
7907660
21.

An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease.

Dyner TS, Lang W, Geaga J, Golub A, Stites D, Winger E, Galmarini M, Masterson J, Jacobson MA.

J Acquir Immune Defic Syndr. 1993 May;6(5):459-65.

PMID:
8097787
22.

Bacillary angiomatosis and bacillary splenitis in immunocompetent adults.

Tappero JW, Koehler JE, Berger TG, Cockerell CJ, Lee TH, Busch MP, Stites DP, Mohle-Boetani J, Reingold AL, LeBoit PE.

Ann Intern Med. 1993 Mar 1;118(5):363-5. No abstract available.

PMID:
8430982
23.

Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects.

Mühler A, Clément O, Saeed M, Lake JR, Stites DP, Berthezène Y, Brasch RC.

Invest Radiol. 1993 Jan;28(1):26-32.

PMID:
8425849
24.

A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects.

Kahn JO, Stites DP, Scillian J, Murcar N, Stryker R, Volberding PA, Naylor PH, Goldstein AL, Sarin PS, Simmon VF, et al.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1321-5.

PMID:
1466950
25.

Prednisone management of HIV-associated recurrent oral aphthous ulcerations.

Silverman S Jr, Gallo J, Stites DP.

J Acquir Immune Defic Syndr. 1992;5(9):952-3. No abstract available.

PMID:
1512698
26.

Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method.

Epling CL, Stites DP, McHugh TM, Chong HO, Blackwood LL, Wara DW.

Cytometry. 1992;13(6):615-20.

27.
28.

Effects of 0.60 PPM nitrogen dioxide on circulating and bronchoalveolar lavage lymphocyte phenotypes in healthy subjects.

Rubinstein I, Reiss TF, Bigby BG, Stites DP, Boushey HA Jr.

Environ Res. 1991 Jun;55(1):18-30.

PMID:
1855487
29.

Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals.

Krowka JF, Singh B, Stites DP, Maino VC, Narindray D, Hollander H, Jain S, Chen H, Blackwood L, Steimer KS.

Clin Immunol Immunopathol. 1991 Apr;59(1):53-64.

PMID:
1708316
30.

Monocyte-mediated lysis of HIV-infected tumor cells.

Debs RJ, Krowka J, Stites D, Brunette EN, Düzgünes N, Philip R.

AIDS Res Hum Retroviruses. 1990 Aug;6(8):1005-9.

PMID:
1699572
31.

Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.

Krowka J, Stites D, Debs R, Larsen C, Fedor J, Brunette E, Düzgünes N.

J Immunol. 1990 Apr 1;144(7):2535-40.

PMID:
1969450
32.

Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics.

Voltarelli JC, Rayner AA, Garovoy MR, Stites DP.

J Biol Response Mod. 1990 Feb;9(1):103-7.

PMID:
2319257
33.

Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco.

Stites DP, Moss AR, Bacchetti P, Osmond D, McHugh TM, Wang YJ, Hebert S, Colfer B.

Clin Immunol Immunopathol. 1989 Jul;52(1):96-103.

PMID:
2785891
34.

Stress reduction training changed number of sexual partners but not immune function in men with HIV.

Coates TJ, McKusick L, Kuno R, Stites DP.

Am J Public Health. 1989 Jul;79(7):885-7.

35.

Immunophenotyping in a multicenter study: the Transfusion Safety Study experience.

Fletcher MA, Azen SP, Adelsberg B, Gjerset G, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Parker JW, Stites DP, et al.

Clin Immunol Immunopathol. 1989 Jul;52(1):38-47.

PMID:
2656018
36.

Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Krowka JF, Stites DP, Jain S, Steimer KS, George-Nascimento C, Gyenes A, Barr PJ, Hollander H, Moss AR, Homsy JM, et al.

J Clin Invest. 1989 Apr;83(4):1198-203.

37.

CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals.

Walker CM, Moody DJ, Stites DP, Levy JA.

Cell Immunol. 1989 Apr 1;119(2):470-5.

PMID:
2495184
39.

Immunological effects of HIV infection.

Krowka JF, Moody DJ, Stites DP.

Immunol Ser. 1989;44:257-303. Review. No abstract available.

PMID:
2535143
40.

Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.

McHugh TM, Stites DP, Busch MP, Krowka JF, Stricker RB, Hollander H.

J Infect Dis. 1988 Nov;158(5):1088-91. No abstract available. Erratum in: J Infect Dis 1989 Mar;159(3):602.

PMID:
3141521
42.

Antibody to c antigen consequent to renal transplantation.

Hjelle B, Donegan E, Cruz J, Stites D.

Transfusion. 1988 Sep-Oct;28(5):496-8.

PMID:
3138795
43.
44.

Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro.

Calman AF, Busch MP, Vyas GN, McHugh TM, Stites DP, Peterlin BM.

AIDS. 1988 Jun;2(3):185-93.

PMID:
2840098
45.

Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Krowka J, Stites D, Mills J, Hollander H, McHugh T, Busch M, Wilhelm L, Blackwood L.

Clin Exp Immunol. 1988 May;72(2):179-85.

46.

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Moss AR, Bacchetti P, Osmond D, Krampf W, Chaisson RE, Stites D, Wilber J, Allain JP, Carlson J.

Br Med J (Clin Res Ed). 1988 Mar 12;296(6624):745-50.

47.

Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco.

Krowka JF, Stites DP, Moss AR, Casavant CH, Carlson JR, Chermann JC, Barre-Sinoussi F, Rodgers RP, Bacchetti P, McHugh TM, et al.

Diagn Clin Immunol. 1988;5(6):381-7.

PMID:
3219786
48.

In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma.

Wong GH, Krowka JF, Stites DP, Goeddel DV.

J Immunol. 1988 Jan 1;140(1):120-4.

PMID:
3121735
49.

Multiparameter flow cytometric analysis of mononuclear cells from HIV-infected individuals.

Moody DJ, Casavant CH, Fulwyler MJ, McHugh TM, Stites DP.

Cytometry Suppl. 1988;3:44-7. Review. No abstract available.

PMID:
3076366
50.

The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.

Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ.

Cell Immunol. 1987 Nov;110(1):140-8.

PMID:
2824064

Supplemental Content

Loading ...
Support Center